Can You Feel the Excitement? Kamala Is Back and in the Lead!
Here's Some Things to Know About Jack Smith Before His Testimony Today
Lefty Trump Supporter Wrecks the Political Class' Whining About Trump at Davos on...
New Hampshire Dem Senate Candidate Totally Melts Down Over This Question About ICE
This Exchange Between Old White Lib Women and a Black ICE Agent Was...
Look At This Woman's Face When She Realized She Had Don Lemon Beat...
Bad News: Abigail Spanberger Is Governor of Virginia. Good News: A Savior Might...
This Primary Race Could Determine Who Dominates the Republican Party
AG Bondi Announces Arrests of Suspects Who Mobbed Minneapolis Church
Jason Crow: Democrats Plan to Impeach Trump If They Regain Power in November
Chicago Mayor Brandon Johnson Just Insulted Justice Clarence Thomas
Here Are the Details of President Trump's Greenland Deal
Gavin Newsom Poses With His Sugar Daddy Alex Soros
Chris Cuomo Goes on Unhinged Rant Against Scott Jennings for Using the Term...
Five Takeaways From the College Football National Championship Game
Tipsheet

Pfizer CEO: Our Vaccines Offer ‘Limited, If Any Protection’

AP Photo/Pablo Martinez Monsivais, File

Speaking during remarks to a J.P. Morgan healthcare conference this week, Pfizer CEO Albert Bourla openly stated current vaccines the company developed for Wuhan coronavirus offer "limited, if any" protection against contracting current variants of the disease. He then encouraged booster shots. 

The statement from Bourla comes as the Biden administration continues to justify vaccine mandates for federal workers, contractors and private businesses. The Supreme Court heard arguments about President Biden's mandates for private companies and medical workers last week. A ruling is expected soon on the constitutionality of the mandates. 

A number of people who have pointed out the waning efficacy of Pfizer's vaccines, which Bourla touted last year as being "100 percent" effective against contracting or transmitting the virus, have been banned by social media companies. 

Meanwhile, Bourla also announced this week the company is developing a vaccine specific to Omicron. It is expected to be ready in March when health officials predict the latest wave of the mild variant will already be over. 

Join the conversation as a VIP Member

Recommended

Trending on Townhall Videos